Thibault Boscart is a doctoral candidate within the IBSP team, as part of a co-supervised thesis project between the UGSF (Structural and Functional Glycobiology Unit) and the IEMN (Institute of Electronics, Microelectronics and Nanotechnology). Holding a Master’s degree in Nutrition and Food Sciences, with a specialization in “Innovations in Plant, Enzymatic, and Microbial Biotechnologies,” he previously completed two internships at UGSF before obtaining a doctoral fellowship.

His research aims to develop an oral administration method for GLP-1 receptor agonists, a class of drugs used in the treatment of type 2 diabetes. These molecules, fragile in the gastrointestinal tract, currently require administration by injection or very high oral doses. To address this challenge, Thibault is exploring two approaches: the production of potatoes synthesizing a starch coupled to the active ingredient, and the manufacture of starch nanoparticles capable of encapsulating and protecting the drug. His work lies at the interface of plant biotechnology, glycobiology, and therapeutic innovation.

> thibault.boscart@univ-lille.fr